Upregulation of CD276 promoted the immune escape of tumor cells and reduced secretion of interleukin-2 (IL-2), tumor necrosis factor-alpha (TNF-α) and other cytokines (Ma et al., 2016). The gene discussed is IL2; the disease is neoplasm.